Table 4.
Bleeding and clotting according to patient demographics
| Bleeding n (%) | Clotting n (%) | P-value | |
|---|---|---|---|
| Age | |||
| ≥75 | 23 (37.70) | 17 (27.87) | 0.1498 |
| <75 | 8 (13.11) | 13 (21.31) | |
| Sex | |||
| Male | 7 (11.29) | 11 (17.74) | 0.2631 |
| Female | 24 (38.71) | 20 (32.26) | |
| INR goal | |||
| 2.5 | 25 (6.19) | 28 (6.93) | 0.314 |
| 3 | 6 (1.49) | 3 (0.74) | |
| Insurance type | |||
| Medicare | 9 (14.52) | 5 (8.06) | 0.2064 |
| Medicare/private | 4 (6.45) | 8 (12.90) | |
| Private | 1 (1.61) | 4 (6.45) | |
| Unknown | 17 (27.4)2 | 14 (22.58) | |
| Indication to treat | |||
| Afib/Aflutter | 21 (33.87) | 22 (35.48) | 0.6769 |
| DVT/PE | 3 (4.84) | 5 (8.06) | |
| MVR/AVR | 6 (9.68) | 3 (4.84) | |
| Other | 1 (1.61) | 1 (1.61) | |
| Comorbidities | |||
| 0–2 | 8 (13.11) | 3 (4.92) | 0.2242 |
| 3–4 | 9 (14.75) | 11 (18.03) | |
| >4 | 13 (21.31) | 17 (27.87) | |
| Medications | |||
| 0–4 | 6 (9.68) | 4 (6.45) | 0.7581 |
| 5–7 | 13 (20.97) | 13 (20.97) | |
| >7 | 12 (19.35) | 14 (22.58) | |
| Herbals | |||
| 0 | 17 (27.42) | 13 (20.97) | 0.3094 |
| ≥1 | 14 (22.58) | 18 (29.03) | |
Abbreviations: n, number; INR, international normalized ratio; Afib/Aflutter, atrial fibrillation/flutter; DVT/PE, deep vein thrombosis/pulmonary embolism; MVR/AVR, mitral/aortic valve replacement.